MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy

MindMaze Therapeutics is supporting a University of Pittsburgh clinical study combining cervical epidural spinal cord stimulation with high-dose, high-intensity neurotherapy to improve arm function in adults with chronic post-stroke upper-limb weakness.

The University of Pittsburgh study, NCT07153536, tests whether intensive, intent-driven practice delivered via MindMaze’s platform can convert the immediate assistive effects of spinal cord stimulation into lasting functional recovery over a six-month follow-up period.

The trial builds on prior research published in Nature Medicine showing that cervical spinal cord stimulation can immediately improve arm and hand movement in people with chronic stroke with only a few hours of training, but the benefits are largely assistive and temporary.

The new study enrolls 20 participants, has them complete a six-week training course, followed by spinal stimulation implantation and repeated training with stimulation active, then up to six months of follow-up to assess how gains are retained.

The combination is designed so that stimulation makes movement possible, the patient’s intent drives it, and a high volume of neurotherapy tests whether lasting recovery can exceed what stimulation alone provides.